Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Bayer VP elected to two of the firm’s executive committees

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, appointment

Dr Monika Lessl has been appointed to Bayer Foundations’ executive committee, selected by the German pharmaceutical firm’s Board of Management …
Appointment

Daiichi Sankyo name current COO Sunao Manabe as firm’s new CEO

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Daiichi Sankyo have said Sunao Manabe, the company’s current COO will take over from George Nakayama as the firm’s new …
Appointment

GW Pharma announce Darren Cline as company’s new Chief Commercial Officer

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

GW Pharmaceuticals have announced the appointment of Darren Cline as the company’s new US Chief Commercial Officer. Cline will lead …
Appointment

Top Ten most popular articles on Pharmafile.com this week!

April 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, BMS, Eisai, Gilead, MSD, Pfizer, ViiV, indivior

This week was an excellent week for recommendations and approvals after Eisai, MSD, Pfizer, BMS and ViiV scored wins. Meanwhile …
News

Living with a rare chromosome disorder

April 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Inv Dup Del 8p, feature, patient experience, pharma

Rebecca Pender’s daughter Hannah lives with the ultra-rare condition Inv Dup Del 8p, a genetic arrangement that affects just 80 …
Feature

Novartis’ Kisqali combo rejected by NICE for advanced breast cancer

April 11, 2019 Sales and Marketing Kisqali, NHS, NICE, Novartis, pharma

Novartis’ Kisqali (ribociclib) has been rejected for use on the NHS by NICE for the treatment of advanced breast cancer, …
News

Gilead to lay off one fifth of sales force

April 11, 2019 Sales and Marketing Gilead, Jobs, Letairis, Ranexa, redundancy, sales

Gilead Sciences is preparing to lay off around a fifth of its salesforce in anticipation for the expiry of patents …
News

FDA green lights Amgen and UCB’s Evenity in postmenopausal osteoporosis patients

April 10, 2019 Research and Development, Sales and Marketing Amgen, Evenity, FDA, UCB Pharma, osteoporosis, pharma

The FDA has decided to approve Amgen and UCB Pharma’s Evenity (romosozumab-aqqg) for the treatment of postmenopausal osteoporosis patients at …
News

Europe approves Lynparza in HER2-, gBRCAm advanced breast cancer

April 10, 2019 Research and Development, Sales and Marketing AstraZeneca, Cancer, MSD, breast cancer, lynparza, pharma

Lynparza (olparib), the poly ADP ribose polymerase (PARP) inhibitor developed by AstraZeneca and MSD, has been awarded marketing approval by …
News

Epilepsy Society calls for review of UK supply chain following “steep rise” in access issues

April 9, 2019 Manufacturing and Production, Sales and Marketing Epilepsy Society, UK, brexit, epilepsy, market access, pharma

The Epilepsy Society has drawn attention to the “steep rise” in UK patients who are encountering difficulty in accessing seizure …
News

FDA refuses to review Zogenix’s Fintepla in Dravet syndrome, shares tumble 30%

April 9, 2019 Manufacturing and Production, Sales and Marketing Dravet Syndrome, FDA, Fintepla, Zogenix

California-based biopharma firm Zogenix has been left frustrated after it received a correspondence from the FDA noting its refusal to …
News

Eisai and MSD’s Lenvima recommended for NHS Scotland in advanced or unresectable liver cancer

April 8, 2019 Manufacturing and Production, Sales and Marketing Cancer, NHS, Scotland, Scottish Medicines Consortium, UK, liver cancer, pharma

Patients in Scotland with with advanced or unresectable hepatocellular carcinoma (HCC) will now be able to access Eisai and MSD’s …
News

Kymab announces Merck exec Simon Sturge as new CEO

April 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, appointment, kymab, pharma

UK-based biotech Kymab has identified Merck KGaA executive Simon Sturge as its new Chief Executive Officer, taking over the reins …
Appointment

Protecting public health: Is real-world evidence the key?

April 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, pharma, real world data, real world evidence, real-world data, real-world evidence

In often tough regulatory climates and with threats to public health are growing in sceptical corners of society, the need …
Feature

NICE turns down Astellas’ Xtandi in prostate cancer

April 8, 2019 Research and Development, Sales and Marketing Astellas, Cancer, NHS, NICE, UK, pharma, prostate cancer

Astellas’ Xtandi (enzalutamide) has been rejected by UK medicines watchdog NICE for use on the NHS as a therapy for …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026